Effect of staggered cyclophosphamide-immunosuppression on resistance to experimental Junin virus infection.
Otherwise resistant adult mice were rendered susceptible to intracerebral Junin virus (JV) infection only when a staggered cyclophosphamide (CY) schedule was used. Forty-five-day old Balb/c mice, intracerebrally JV-infected and immunosuppressed with four 50 mg/kg body weight CY doses at days -1, +1, +4, +6 (day 0: viral infection) developed a lethal disease (86.6 per cent mortality) with high CNS viral titers and brain lesions. Neutralizing antibodies were absent throughout, while immunofluorescent antibody levels were considerably diminished. The transfer of hyperimmune serum conferred partial though significant protection on CY-treated animals but no correlation was found between CNS viral titers and mortality since in both infected CY-treated and untreated mice similar brain viral content was found. This was also confirmed by immune spleen cell transfer at day 0 where the clearance achieved was unable to modify the time course of the disease. Feasible mechanisms explaining recovery from JV infection by means of the protective effect of antibodies and the cell-mediated clearance are discussed.
Barrios
H A
HA
Rondinone
S N
SN
Giovanniello
O A
OA
Lascano
E F
EF
Nota
N R
NR
D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis; D006477:Arenaviruses, New World / Q000254:growth & development / Q000276:immunology; D001921:Brain / Q000382:microbiology / Q000473:pathology; D003520:Cyclophosphamide / Q000494:pharmacology*; D006478:Hemorrhagic Fever, American / Q000276:immunology* / Q000382:microbiology / Q000473:pathology; D007111:Immunity, Cellular; D007116:Immunization, Passive; D007165:Immunosuppression Therapy; D051379:Mice; D008807:Mice, Inbred BALB C; D009500:Neutralization Tests
D000914:Antibodies, Viral; D003520:Cyclophosphamide